Protein-Protein Interaction Conference 2019

Modulating disease-relevant protein-protein interactions (PPIs) or protein-nucleic acid complexes by chemical agents is a strategy for discovering new compounds with therapeutic potential. However intracellular PPIs are harder to rationally design drugs against or screen in a traditional high-throughput biochemical assay than are traditional intracellular targets such as enzymes. PPIs lack an active site to target.